Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection by unknown
PHENOTYPE, SPECIFICITY, AND FUNCTION OF
T CELL SUBSETS AND T CELL INTERACTIONS
INVOLVED IN SKIN ALLOGRAFT REJECTION
BY AMY S. ROSENBERG, TOSHIAKI MIZUOCHI, SUSAN O. SHARROW, AND
ALFRED SINGER
From theImmunology Branch, National Cancer Institute, National Institutes ofHealth,
Bethesda, Maryland 20892
The T cell populations involved in the rejection of skin allografts remain
controversial (1-6). It is unclear whether skin allograft rejection is mediated by
lymphokine secreting T helper (Th) cells, cytolytic T killer (Tk)' cells, dual
function T cells (7, 8), or by interactions between functionally distinct T cell
subsets. It has recently been appreciated (9-11) that phenotypically distinct
populations of L3T4+ and Lyt-2+ T cells are each able to mediate skin allograft
rejection. It is also known that phenotypically distinct populations ofL3T4+ and
Lyt-2+ T cells are functionally heterogeneous, each containing lymphokine-
secreting Th cells and cytolytic Tk cells (12-15). Moreover, phenotypically
distinct populations of L3T4' and Lyt-2+ T cells express distinct recognition
specificities (16), as do functionally distinct but phenotypically identical popula-
tions ofTh and Tk cells (17-19).
Despite the complexities, it is important to understand the T cell mechanisms
involved in skin allograft rejection. Recently, by correlating the phenotype,
specificity, and function of H-2b T cells responding in vitro to MHC class I Kb
mutant alloantigens with the in vivo rejection by H-2b mice of Kb mutant skin
grafts, we identified class I-allospecific Lyt-2+ Th cells as the critical cell type
determining the rejection rate of class I-disparate skin allografts (9). By using
further in vitro insights to analyze in vivo allograft rejection, we have now
compared the phenotype, specificity, and functional capabilities ofdefined T cell
subpopulations with their ability to initiate and mediate the in vivo rejection of
skin allografts expressing a variety of defined alloantigens. The results of this
analysisare straightforward: without exception, skin allograft rejection occurred
only in mice containing T cell populations that, by in vitro assessment, contained
both Th and Tk cells specific for the alloantigens of the graft. However, for
graft rejection to occur, the cellular elements of the skin allograft must be able
to trigger the Th and Tk cells present in the host.
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Animals.
￿
B10 nu/nu female mice were obtained from the Small Animal Section, NIH,
Bethesda, MD. C57BL/6 (B6), B10, B10.BR, and DBA/2 mice were obtained from The
Jackson Laboratory, Bar Harbor, ME. B6.PL-Thy-la (B6-Thy-1.1) mice (20) were a
generous gift of Dr. John Wunderlich from the Frederick Cancer Research Facility,
Frederick, MD. B6.CH-26m' (bml) (21), B6.CH-26'" 12 (bm12) (22), B6.CH-26-6 (bm6) (23),
(bm6 x bm12)F,, and B6.Tlaa mice (24) were bred in our own animal facility. B10 nude
mice were 6-14 wk old at the time of engraftment and adoptive transfer. B6 mice were
13-16 wk old at the time of engraftment. The MHC haplotypes ofthe various strains are
listed in Table 1.
Monoclonal Antibodies.
￿
Anti-L3T4 mAb was either a culture supernatant of the hybri-
doma cell line GK 1.5 (25), generously provided by Dr. Frank Fitch, University ofChicago,
Chicago, IL, or an ascitic fluid of the hybridoma cell line RL-172/4 (26), generously
provided by Dr. Ada Kruisbeek, NIH. Anti-Lyt-2.2 mAb was a culture supernatant of the
hybridoma cell line 83-12-5, generously provided by Dr. Jeffrey Bluestone, NIH.
Isolation of T Cell Subpopulations.
￿
Depletion of L3T4+ T cells or Lyt-2+ T cells was
accomplished by incubating spleen cells at a density of 107 cells/ml with anti-L3T4 (1 :2
dilution of GK1.5 or a 1:100 dilution of RL-172/4) or anti-Lyt-2.2 (1 :5 dilution) mAbs
for 30 min at 37'C. Cells were then pelleted, resuspended in C, and incubated for 50
min at 37°C. The cells treated with GK1.5 were resuspended at 107/ml in rabbit
complement (Cedar Lane Laboratories Ltd., Ontario, Canada) diluted 1:10. The cells
treated with RL-172/4 and 83-12-5 were resuspended at 108/ml in Guinea pig comple-
ment (Gibco Laboratories, Grand Island, NY) diluted 1:3. Treated cells were washed
threetimesbefore injection into experimental animals. To avoidtheconfusion ofreferring
to T cell populations in negative terms, anti-Lyt-2 plus C-treated spleen cells will be
referred to as L3T4+ T cells and anti-L3T4 plus C-treated spleen cells will be referred
to as Lyt-2+ T cells.
Skin Grafting of Normal B6 Mice.
￿
B6 mice were engrafted either on the left flank or
on both flanks with tailskin grafts according to an adaptation of the method of Billingham
and Medawar (27). Bandages were removed on day 7 and the grafts were scored daily
until rejection (defined as loss of >80% of the grafted tissue) or the end point of the
experiment.
Skin Grafting and Adoptive Transfer.
￿
Female B10 nude mice were engrafted on the
thorax on day 0 with tailskin allografts from donor mice according to an adaptation of
the method of Billingham and Medawar (27). On day 1, the mice were injected intrave-
nously with 5-7 x 107 spleen cells from unprimed B6 mice or B6 Thy-1.1 congenic mice
that had been (a) untreated, (b) treated with anti-L3T4 plus C in vitro, or (c) treated with
anti-Lyt-2.2 plus C in vitro according to the above procedures. Bandages were removed
Strain
H-2
lA
alleles
IE D Qal
C57BL/6 (B6) b b - b b
C57BL/10 (B10) b b - b
B6.PL-Thy-la (B6-Thy-1.1) b b - b
B10.BR k k k k
DBA/2 d d d d
B6.CH-26'"' (bin I) bml b - b
B6.CH-2"s (bm6) bm6 b - b
B6.CH-26,12 (bm12) b bm12 - b
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on day 7 and the grafts were scored daily until rejection (defined as loss of >80% of the
grafted tissue) or the end point of the experiment.
Reagents Usedfor Flow Cytometry (FCM).
￿
Anti-Fc receptor mAb (2.4G2) (28) and biotin-
conjugated monoclonal anti-L3T4 (GK1 .5) (25) were generous gifts from J. Titus (Im-
munology Branch, National Cancer Institute). FITC anti-Thy-1 .2 (clone 30-H12), FITC-
anti-Leu-1, biotin-conjugated anti-Lyt-2 (clone 53-6), and biotin-conjugated anti-Leu-1
were purchased from Becton Dickinson Immunocytometry Systems (Mountain View, CA).
Texas Red (TR)-Streptavidin was purchased from Bethesda Research Laboratories, Be-
thesda, MD. Anti-Fc receptor antibody (2.4G2) was used to block Fc receptor-mediated
antibody binding during the staining procedures.
Flow Cytometry Analysis.
￿
Multicolor FCM was performed as previously described (29)
using a modified FAGS II (Becton Dickinson Immunocytometry Systems) equipped with
(a) the manufacturer's filters and photomultiplier tubes, (b) argon ion laser for FITC
excitation (488 nm), (c) pumped dye (rhodamine 6G) laser for TR excitation (590 nm),
and it was interfaced to a Digital Equipment Corp. (Marlboro, MA) PDP 11/2423 (30).
Fluorescence data were collected using logarithmic amplification on 50,000 viable cells as
determined by forward light scatter intensity and propidium iodide exclusion. Logarithmic
amplification was provided by a three-decade logarithmic amplifier constructed from an
NIH-modified design of R. Hiebert, LASL (Los Alamos Scientific Laboratories, Los
Alamos, NM). One-color fluorescence data were displayed as cell frequency histograms
or immunofluorescence profiles in which log fluorescence intensity was plotted in 1,024
channels on the x-axis and cell number shown on the y-axis. Two-color immunofluores-
cence data were displayed as contour diagrams in which log intensities of green (FITC)
fluorescence were plotted in 64 channels on the x-axis and the log intensities of red (TR)
fluorescence were plotted on the y-axis. Constant values of the percentage of total cell
number on the z-axis were selected to draw the rings or contours around peaks of cells
correlating FITC and TR fluorescence.
Results
Experimental Model. To assess the T cell subpopulations involved in skin
allograft rejection, we used an adoptive transfer model in which H-2b nude mice
were engrafted on day 0 with tailskin allografts and reconstituted on day 1 with
50-70 x 106 syngeneic H-2b spleen cell subpopulations. To determine if skin
allograft rejection in this model depended upon reconstitution with immunocom-
petent T cells, B10 nude mice engrafted with B10 .BR (H-2') skin were reconsti-
tuted with unfractionated spleen cells from either normal B 10 or T cell-deficient
nude 1310 mice . As can be seen in Fig. 1, nude mice given normal B10 spleen
cells rejected their skin allografts rapidly whereas nude mice given T cell deficient
B10 spleen cells failed to do so . Unreconstituted nude mice also failed to reject
the skin allografts (data not shown) . These data indicated that the ability to reject
skin allografts in this model was contingent upon the adoptive transfer of
immunocompetent T cells.
Skin Allograft Rejection by Negatively Selected Populations ofPhenotypically Distinct
T Cells. We next tested the ability of phenotypically distinct T cell subpopula-
tions to induce graft rejection. B10 nude mice engrafted with fully allogeneic
DBA/2 skin grafts were reconstituted with H-2b spleen cells that were (a)
untreated, (b) treated with anti-L3T4 plus C, generating a T cell population that
was overwhelmingly Lyt-2' (<I% of the remaining T cells were L3T4''), or (c)
treated with anti-Lyt-2 plus C, generating a T cell population that was over-
whelmingly L3T4' (<I% of the remaining T cells were Lyt-2+). To avoid the100
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FIGURE 1 .
￿
Rejectionof skin allografts by nude mice
reconstituted with normal but not T cell-deficient
spleen cell populations. B10 nude mice were engrafted
on day 0 with MHC-disparate B10.BR tail skin grafts,
andwere reconstitutedon day 1 with 50 X 106 spleen
cells from either B10 normal mice or T cell-deficient
B10 nude mice. Thenumber of mice in each group is
indicated. Thegrafts were scored daily untilrejection
or death of the animal.
confusion of referring to T cell populations in negative terms, anti-Lyt-2 plus
C-treated spleen cells are referred to as L3T4' T cells and anti-L3T4 plus C-
treated spleen cells are referred to as Lyt-2' T cells. As can be seen in Fig. 2, all
three H-26 T cell populations effected the rapid rejection of DBA/2 skin
allografts. In contrast to their rejection ofallogeneic grafts, reconstituted nude
mice failed to reject syngeneic B6 skin grafts (data not shown). These results
indicated that negatively selected populations ofL3T4' and Lyt-2' Tcells were
each able to mediate skin allograft rejection. However, it was possible that cells
of the reciprocal phenotype derived from either the nude host or from residual
cells in the donor innoculum contributed to the rejection of skin allografts in
this adoptive transfer model.
To assess the possibility that cells derived from the nude host contributed to
skin allograft rejection, we performedan experiment in which donor H-2bspleen
cells were from B6-Thy-1 .1 congenic mice. Since mature T cells of B10 nude
host origin would be Thy-1 .2', they would be discernible from T cells derived
from the Thy-1 .1 donor innoculum. Accordingly, B6-Thy-1.1 spleen cell popu-
lations were injected into B10 nude mice that had been engrafted with fully
allogeneic DBA/2 skin grafts to provide maximal stimulation for the expansion
of small numbers of host-derived T cells. Further, the mice were reconstituted
with isolated T cell populations as well as unseparated Tcell populations in the
event that reconstitution with unfractionated Tcell populations suppressed the
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￿
Isolated Lyt-2' and L3T4' T cell
populations can reject fully allogeneic skin
grafts. B10 nude mice were engrafted on day
0 with DBA/2 tail skin grafts, and were recon-
stituted on day I with 50 X 106 B6 spleen cells
that were untreated, L3T4+ (negatively se-
lected with anti-Lyt-2 plus C), or Lyt-2+ (nega-
tively selected with anti-L3T4 plus C). The
number of mice in each group is indicated.
Grafts were scored daily until rejection. Con-
trol, reconstituted mice retained syngeneic B6
skin grafts indefinitely.
appearance of T cells of nude host origin. All mice reconstituted with either
unfractionated or isolated H-26 T cell populations rejected their DBA/2 skin
grafts (MST ranged between 11 and 16 d for each of the three groups). 35 d
after reconstitution, spleen cells from the reconstituted mice were examined for
mature T cells of nude host origin by staining with fluoresceinated anti-Thy-1 .2
and a mixture of biotinylated anti-Lyt-2 and anti-L3T4. It can be seen in Fig.
3a and Table 11 that while rare cells expressing Thy-1.2 were present in
unreconstituted nude mice, they were overwhelmingly L3T4-,Lyt-2-. This con-
trasted markedly with spleen cells from either B10 normal mice (Fig. 3 b) or B10
nude mice reconstituted with Thy-1.2+ spleen cells (Fig. 3c). In these latter
animals 18-20% ofspleen cells were positive for both Thy-1.2 and L3T4/Lyt-
2. Spleens ofnude mice reconstituted with either unfractionated or isolated Thy-
1.1 congenic spleen cells containedsignificant numbers ofThy-1 .2-cells express-
ing L3T4/Lyt2, but Thy1.2+ cells expressing L3T4/Lyt2 were virtually unde-
tectable (<0.5%) (Fig. 3, df, and Table II). We assessed the same parameters
on days 42 and 76 and observed identical results (data not shown). Thus, at least
over the time period necessary for most skin graft experiments, there was no
evidence indicating the appearance of mature T cells ofnude host origin in the
spleens of the adoptively transferred mice.
To assess the alternative possibility, that significant in vivo expansion of
contaminating T cells from the donor spleen cell innoculum occurs, B10 nudeZ
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￿
Failure to detect Lyt-2+ or L3T4' T cells of nude host origin in adoptively
transferred mice. B10 nude mice were engrafted on day 0 with a DBA/2 tail skin allograft,
and were reconstituted on day 1 with 50 x 106 spleen cells from either syngeneic B6 or B6-
Thy-1.1 congenic mice that were untreated, treated with anti-L3T4 plus C, or treated with
anti-Lyt-2 plus C. On day 35, spleen cells from these experimental mice, as well as from
unreconstituted B10 nu/nu and B10 normal mice, were analyzed by two-color FCM for cells
expressing Thy-1.2 vs. L3T4/Lyt-2. Anti-Leu-1 is a negative control antibody. Quadrants
selected for data integration are shown by solid lines on the contour profiles. These x and y
levels were chosen as the intersection of profiles of positive and control negative antibodies
reacted with spleen cellsfrom B10 nu/nu animals that received untreated Thy-1.2 spleen cells.
(Green: FITC-anti-Thy-1 .2 vs. FITC-anti-Leu-1 ; red: biotin-anti-L3T4 plus biotin-anti-Lyt-
2 vs. biotin-anti-Leu-1, data not shown). SeeTable II for percent ofspleen cells stained.
mice engrafted with allogeneic skin grafts were reconstituted with either unfrac-
tionated or isolated spleen T cell populations. On days 30 and 60 following
reconstitution, the phenotypes of their splenic T cells were assessed. As can be
seen in Fig. 4, mice that had received untreated B6 spleen cells 30 d previously
contained both Lyt-2+ and L3T4+ Tcell populations. This contrasted markedly
with mice receiving isolated T cell populations: mice receiving Lyt-2 plus C-
treated cells had <1.0% Lyt-2+ spleen cells 30 d after reconstitution, and mice
receiving L3T4 plus C-treated cells had <1 .0% L3T4+ spleen cells. Similar
results were obtained on day 60 after reconstitution (data not shown) . From
these studies it would appear that minimal expansion ofcontaminating T cells in
the original donor innoculum occurred in vivo over the time course of the
experimental assays.
Specificity of Skin Allograft Rejection by Phenotypically Distinct T cell Popula-
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TABLE II
Phenotypes of Spleen Cells Observed in Adoptively Transferred Mice
Displayed in Fig. 3
Numbers have not been corrected for background staining and thus
represent the maximum possible frequency. Thy-1.2+,Leu-l+ back-
ground staining ranged between 0.07 and 0.15%.
* Correspond to panels in Fig. 3.
tions.
￿
It was clear from the experiment shown in Fig. 2 that each phenotypically
distinct T cell population could effect the rejection offully allogeneic skin grafts.
To more precisely identify the antigen specificities triggering allograft rejection
responses by each isolated T cell phenotype, we engrafted B10 nude mice with
(a) MHC class I-disparate bml skin grafts, (b) MHC class II-disparate bm12
skin grafts, or (c) multiple minor H-disparate BALB.B skin grafts and we
reconstituted them with unfractionated or isolated H-2b T cell populations. As
can be seen in Fig. 5 (left), unfractionated T cell populations containing both
L3T4+ and Lyt-2+ T cell populations effected the rapid rejection of MHC class
I, MHC class II, and multiple minor H disparate grafts. As can be seen in Fig. 5
(middle), the isolated L3T4+ T cell population effected the rapid rejection of
MHC class II and minor Hdisparate grafts, but did not effect the rapid rejection
of MHC class I disparate grafts. Indeed, B10 nude mice reconstituted with
isolated L3T4+ T cells retained MHC class I-disparate bml skin allografts
indefinitely (>300 d). In contrast, it can be seen in Fig. 5 (right) that the isolated
Lyt-2+ T cell population did effect the rapid rejection of MHC class I-disparate
grafts, but did not effect the rapid rejection of MHC class II- or minor H-
disparate grafts. It might be noted that the reciprocal abilities of isolated L3T4+
and Lyt-2' T cell populations to effect the rejection of MHC class II- and class
I-disparate skin grafts, respectively, but not vice versa, further support the
conclusion that, in this experimental model, Tcells ofthe inappropriate pheno-
type from either the nude host or the donor inocula do not expand to sufficient
numbers to significantly influence the experimental outcome. Thus, this exper-
iment demonstrates that isolated populations of L3T4+ and Lyt-2+ T cells can
Percent of Spleen Cells that Stained with:
Panel* Thy-1.2: - + +
L3T4/Lyt-2: + - +
a 1.3 1.8 0.14
b 1.0 3.7 20.20
c 1.6 2.0 18.11
d 16.0 1.1 0.37
e 6.7 0.6 0.03
f 12.4 1.2 0.04
Leu-l: - + +
L3T4/Lyt-2: + - +
9 16.2 0.01 0.09
h 7.5 0.01 0.07
i 13.1 0.01 0.15100
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FIGURE 4. Failure to detect in vivo expansion of contaminating T cells after adoptive
transfer. B10 nude mice were engrafted on day 0 with allogeneic skin grafts, and were
reconstituted on day 1 with 50 X 106 B6 spleen cells that were untreated, treated with anti-
Lyt-2 plus C, or treated with anti-L3T4 plus C. Before injection, these cell populations were
analyzed by FCM, and it was found that the cells ofthe untreated donor inoculum were 18%
L3T4+and 11 % Lyt-2+; the cells oftheanti-Lyt-2 plus C-treateddonorinoculum were 16.6%
L3T4*and <1% Lyt-2+; and the cells of the anti-L3T4 plus C-treated donor inoculum were
<1% L3T4+ and 10% Lyt-2+. 30 d after reconstitution, the phenotypes of the spleen cells of
mice from each group were assayed by FCM. Solid lines represent staining with either
fluoresceinated anti-L3T4 or anti-Lyt-2 mAbs. Dotted lines represent control staining with
fluoresceinated anti-Leu-1 mAb. Intensity levels for curve integration were chosen as the
intersection of profiles for positive (-) and negative (---) antibodies reacted with spleen cells
from animals that received untreated cells. Percentages of positive cells were determined as
the difference above these levels between positive cells incubated with the experimental
antibody andpositive cells incubatedwith the control antibody.
each individually effect allograft rejection, but only in response to specific and
different alloantigens.
This observation indicates that within each phenotypically distinct T cell
subpopulation are cells with the appropriate specificity and the requisite func-
tional abilities to mediate the rejection process. Interestingly, Lyt-2+ T cell
populations, which rejected class I-disparate grafts, are known from in vitro
studies to possess both lymphokine-secreting Th cells and lymphokine-responsive
Tk cells specific for class I alloantigens (9, 15, 16, 19, 31), and L3T4+ T cell
populations, which rejected MHC class II- and multiple minor H-disparate
grafts, are similarly known to possess both lymphokine-secreting Th cells and
lymphokine-responsive Tk cells specific for these alloantigens (13, 14, 17, 19,
31). Lyt-2+ T cell populations that failed to rapidly reject MHC class 11- and
minor H-disparate grafts contain Tk cells (13, 14, 19, 32-34) but lack Th cells
(19, 31, and Mizuochi, T., A. S. Rosenberg, and A. Singer, manuscript in1304 T CELL SUBSETS AND INTERACTIONS IN ALLOGRAFT REJECTION
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￿
Reconstituting spleen cell populations. Specificity of skin allograft rejection by
phenotypically distinct T cell populations. B10 nude mice were engraftedon day 0 with bral,
bm12, or BALB.B skin grafts, andwere reconstitutedon day 1 with 50 x 106B10 spleen cells
that were unfractionated (left), L3T4' by negative selection with anti-Lyt-2 plus C (center), or
Lyt-2' by negative selection with anti-L3T4 plus C (right). Number of mice in each group is
indicated. Grafts were scored daily until rejection or day 60. Control, reconstituted mice
retained syngeneic B6 skin grafts indefinitely.
preparation) specific for these alloantigens; and L3T4+ T cell populations that
failed to rapidly reject MHC class 1-disparate grafts contain Th cells (15, 19, 31,
35-37) but lack Tk cells (14, 17, 19) specific for MHC class I alloantigens. Thus,
in Fig. 5, it appears that isolated Lyt-2+ and L3T4+ T cell populations rejected
only those skin allografts for which they contained both Th and Tk cells. With
regard to minor H-specific T cell populations, we have consistently failed to
detect minor H-specific Lyt-2+ T cells that either secrete lymphokine or provide
help for in vitro CTL responses, despite numerous and intense efforts involving
multiply immunized and skin engrafted animals (Mizuochi, T., A. S. Rosenberg,
and A. Singer, manuscript in preparation). However, Lyt-2+ proliferative cyto-
lytic T cell clones specific for the minor locus H-1 have been reported (38),
although it is unclear whether H-1 is unique among minor H loci. Nevertheless,
it is conceivable that minor H-specific Lyt-2+ Th cells are present in frequencies
that have escaped our detection but that are responsible for the slow rejection
of minor H-disparate BALB.B skin allografts in some of the experimental mice
(Fig. 5, right).
Skin AllograftRejection Resultingfrom Interactions Between Phenotypically Distinct
T Cell Subsets. To directly test the implication that both inducer and effector
T cell functions are required to initiate and mediate skin allograft rejection, we
turned to a system in which Th and Tk in vitro functions are mediated by
phenotypically distinct T cell populations and so are readily separable (32, 33,
39, 40). The generation in vitro of cytolytic immune responses to the male-
specific antigen H-Y required collaboration between L3T4+ Th cells and Lyt-2+
Tk cells (40). To determine the phenotype of the T cells required in vivo to
reject H-Y skin allografts, we engrafted female H-26 nude mice with B6 malea
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Interactions between phenotypically distinct T cell populations in therejection of
H-Y-disparate skin allografts. (A) Female B10 nude mice were engrafted with B6 male tail
skin grafts on day 0 and the followingdaywere reconstituted with 70 X 106female B6 spleen
cells that were untreated, L3T4' by negative selection with anti-Lyt-2 plus C, or Lyt-2' by
negative selection with anti-L3T4 plus C. (B) Female B10 nude mice were engrafted with B6
male tail skin grafts on day 0 and the following day were reconstituted with 70 X 106
unfractionated or fractionated female B6 spleen cells. Mice reconstituted with both L3T4'
and Lyt-2' spleen cell populations received 35 X 106 of each. (C) Female B10 nude mice were
engraftedwith B6 male tail skin grafts on day 0 andthe followingday were reconstituted with
50 X 106 female B6 spleen cellsthat were L3T4' by negative selection with anti-Lyt-2 plus C.
On day 60, the mice were injected with an additional 50 X 106 female B6 spleen cells that
were Lyt-2' by negative selection with anti-L3T4 plus C. Grafts were scored daily until
rejection or the end of each experiment. Number of mice in each groupis indicated. Control,
reconstituted mice retained B6 female skin grafts indefinitely.
tailskin grafts and reconstituted them with H-2b female spleen cell subpopula-
tions. Fig. 6a reveals the results of our initial studies: neither isolated L3T4+
nor Lyt-2+ T cell populations effected the rejection of H-Y disparate skin grafts,
whereas the untreated T cell population that contained both L3T4+ and Lyt-2+
T cells did effect the rejection of these grafts. To more formally test the need
for T cells of both phenotypes to effect the rejection of H-Y disparate grafts, we
engrafted H-2b female nude mice with B6 male skin and reconstituted them with
untreated, L3T4+,Lyt-2+, or a mixture of T cell populations from female H-2b
mice (Fig. 66). Total cell number was kept constant among the groups . In Fig.
6b it is clear that only mice reconstituted with both L3T4+ and Lyt-2+ T cell
subpopulations rejected H-Y-disparate skin grafts. In a final experiment, H-2b
female nude mice engrafted with B6 male grafts were initially reconstituted with
isolated L3T4+ T cells (Fig. 6c). As before, such mice failed to reject their grafts.
On day 60 these mice were additionally given isolated Lyt-2+ T cells, and shortly
thereafter, began rejecting their H-Y-disparate skin allografts (Fig. 6c). In
contrast, such mice not additionally given isolated Lyt-2+ T cells retained their
H-Y-disparate skin grafts indefinitely (>300 d). Thus, unlike the rejection of
MHC class I and class II disparate skin allografts, the rejection of H-Y-disparate
skin allografts required interactions between L3T4+ and Lyt-2+ T cells. Since1306 T CELL SUBSETS AND INTERACTIONS IN ALLOGRAFT REJECTION
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L3T4+ T cell populations contain H-Y-specific Th cells and Lyt-2+ T cell
populations contain H-Y-specific Tk cells, these results are consistent with a
requirement for in vivo collaboration between H-Y-specific inducer and effector
cells to reject H-Y-disparate skin grafts.
Skin Allograft Rejection Resultingfrom Interactions Between T Cells with Different
Antigen Specificities. In the course of our studies on skin allograft rejection, we
encountered two situations in which normal B6 mice failed to reject allogeneic
skin grafts (9, 41). Thus, most B6 mice failed to reject either Qala or K` skin
allografts (Fig. 7), indicating a deficiency in Qala-specific and Kbm6-specific in-
ducer T cell function, effector T cell function, or both. To examine whether an
antigen-specific deficiency in inducer T cell function was the sole basis for the
failure of normal 136 mice to reject these two types of skin allografts, we asked
whetheranti-Qalaor anti-K"" effector cells were present in B6 mice and whether
they could be activated in vivo by inducer T cells with a different antigen
specificity to effect the rejection of Qala or Kbn,s skin allografts. Consequently,
in the following experiments normal B6 mice were engrafted simultaneously
with two skin grafts : (a) on the left flank, an inducer graft bearing both the
target antigen (either Qala or Kbn'6) as well as additional helper determinants,TABLE III
Rejection ofQal° Skin Allografts Induced by H-Y CarrierDeterminants
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and (b) on the right flank, an indicator graft bearing only the target antigen. In
this way we asked if the T cell response to the inducer graft resulted in the
activation of effector T cells capable of rejecting the indicator graft.
In the first experiment of this type, we assessed the ability of Qala-specific
effector cells to be activated by H-Y-specific Th cells to subsequently reject Qala
skin allografts (Table III). In the absence of an inducer graft expressing putative
helper determinants, B6 female mice failed to reject Qala disparate indicator
grafts (group 1). However, in the presence of an inducer graft expressing both
Qala target antigens and H-Y helper determinants, B6 female mice rapidly
rejected the indicator grafts expressing Qala alloantigens alone, and also rapidly
rejected the inducer grafts (group 2). This rejection of the Qala indicator grafts
reflected the activation of Qala-specific effector cells and did not simply reflect
crossreactive recognition of Qala alloantigens by H-Y-specific effector cells since
most mice engrafted with inducer grafts expressing H-Y-antigens alone failed to
reject the Qala indicator grafts (group 3) . Further, the activation of Qala-specific
effector cells by Qala plus H-Y-expressing inducer grafts required activation of
H-Y-specific T cells since such inducer grafts, when placed on B6 male mice that
cannot recognize H-Y allodeterminants, failed to activate effector cells capable
of rejecting the Qala indicator grafts (group 4). This experiment demonstrates
that B6 mice do contain Qala-specific effector cells and that such cellscan interact
with H-Y-specific T-inducer cells or their products to effect the rejection of Qala-
disparate skin grafts.
In the second experiment of this type, we asked if Kbmfi-specific effector cells
were present in B6 mice and whether they could collaborate with bm 12-specific
T-inducer cells to effect the rejection of Kbmfi skin allografts (Table IV, Exp. 1).
In the absence ofan inducer graft expressing putative helper determinants, most
B6 mice failed to reject the indicator Kbtn6 skin allografts (groups 1, 2). However,
in the presence of an inducer graft expressing both the Kbmfi target antigen and
the 1bm12 helper determinants, normal B6 mice rapidly rejected the indicator
grafts expressing Kbn,6 alloantigenic determinants alone, as well as rapidly reject-
ing the inducer grafts (group 3). Even though it was extremely unlikely that the
rejection of Kbtn6 indicator grafts resulted from crossreactive recognition by Ibm12-
specific effector cells, we performed an experiment to document that L3T4+
Ibtn12-specific T cells activated by the inducer grafts were not the cells directly
responsible for rejectingthe indicator grafts. B10 nude mice engrafted with both
inducer skin grafts and Kbn,6 indicator skin grafts were reconstituted with either
Left (inducer)graft Right(indicator)graft
Group Host Antigenic Fraction Antigenic Fraction Strain Sex disparity MST rejecting Strain Sex disparity MST rejecting
d d
1 B6 F B6.Tla' F Qal' >83 0/4 B6.Tla' F Qal' >83 0/4
2 B6 F B6.Tla' M Qal' + H-Y 21 9/9 B6.T1a' F Qal' 23 9/9
3 B6 F B6 M H-Y 25 9/9 B6.Tla' F Qal' >83 3/9
4 B6 M B6.Tla' M Qal' >83 0/3 B6.Tla' F Qal' >83 0/31308 T CELL SUBSETS AND INTERACTIONS IN ALLOGRAFT REJECTION
TABLE IV
Rejection ofbm6 Skin Allografts Induced by AllogeneicMHC Class II Helper Determinants
Left (inducer) graft
￿
Right (indicator) graft
* Spleen cell populations from normal B6 mice that were either untreated and so contained both L3T4' and Lyt-2* T cells, or were L3T4 *
by negative selection with anti-Lyt-2 plus C.
untreated or isolated L3T4+ T cell populations (Table 111, Exp . 2) . In the
absence of an inducer graft expressing helper determinants, B10 nude mice
reconstituted with untreatedT cell populations failed to reject the
Kbms indicator
grafts (group 4) . However, in the presence of an inducer graft expressing both
the Kbms target antigen and the
Ibml2 helper determinants, such mice rapidly
rejected their Kbm
s indicator grafts, as well as their inducer grafts (group 5) . This
rejection of
Kbm6 indicator grafts was not mediated by Ibm12_specific effector cells,
but rather was mediated by
Kbms-specific effector cells activated by
lb,12-specific
T-inducer cells since the L3T4+ Ibm12-specific effector cells that rejected the
inducer grafts were incapable of rejecting the
Kbt»6 indicator grafts (group 6) .
Thus, the experiments in Table IV demonstrate that B6 mice do contain
Kbtns-
specific effector cells and that such cells can productively interact with
Kbm12_
specific inducer cells or their products to effect the rapid rejection of Kbms skin
allografts .
The experiments summarized in Tables III and IV make two points . First,
they demonstrate in normal mice that skin allograft rejection can be mediated
by interactions between distinct subsets of T-inducer and T-effector cells, and
that the interacting T cells need not recognize the same antigen specificities .
And second, these experiments indicate that an inability to reject specific allo-
grafts can reflect a selective deficiency in antigen-specific Th/T-inducer cells .
Discussion
In the present study we used an adoptive transfer model to assess the pheno-
type, specificity, and functional capability of theT cells involved in initiating and
mediating skin allograft rejection . The results of this study demonstrate that skin
allograft rejection is neither unique to a specialized subset ofT cells with a given
Lyt phenotype, nor unique to a specialized subset of helper-independent effector
T cells with so-called dual function capability . Rather, this study indicates that
skin allograft rejection can be mediated by in vivo collaborations between T-
inducer cells and T-effector cells, and that the two interacting T cell subsets can
express different Lyt phenotypes as well as different antigen specificities . The
present study also demonstrates that a selective deficiency in antigen-specific T-
Exp. Group Host
Reconstituting
H-26 spleen
cell population* Strain
Antigenic
disparity
MST
d
Fraction
rejecting
Strain
Anti-
genic
disparity
MST
d
Fraction
rejecting
1 I B6 - None - - - bm6
Kbm6 >60 3/10
2 B6 - bm6 Kb.6 >60 3/10 bm6
Kbm6 >60 3/10
3 B6 - bm12xbm6 I"3 + Kbm6 14 12/12 bm6 Kb.6 15 .5 11/12
2 4 1110 Nude L3T4` + Lyt-2* bm6 Kb.6 >64 0/6 bm6 Kb.6 >64 0/6
5 B 10 Nude L3T4* + Lyt-2* b.12 x bm6
16-12+Kbm6 15 5/5 bm6 Kb.6 18 5/5
6 1110 Nude L3T4* bm l2 x bm6 I"" + Kb.6 10 4/4 bm6 Kb "'6 >64 0/4ROSENBERG ET AL.
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inducer cells results in a failure to reject specific skin allografts despite the
presence of antigen-specific T-effector cells. The Lyt phenotype and antigen
specificity of T cells that function as T-inducer and T-effector cells for in vivo
allograft rejection responses parallel closely those of T cells that function as
lymphokine-secreting Th and lymphokine-responsive Tk cells for in vitro cyto-
lytic T cell responses. Indeed, in vivo skin allograft rejection was observed only
in those mice whose T cell populations contained, by in vitro assessment, both
Th and Tk cells reactive against the alloantigens of the graft.
The experimental model system that we used involved the reconstitution of
skin-engrafted B10 nude mice with either whole spleen cell populations or
negatively selected spleen cell subpopulations from naive H-2b mice. In theory,
it was possible that reconstituted nude mice contained T cells derived either
from the nude host animal (42) or from contaminants in the reconstituting T
cell population. However, flow cytometry failed to detect significant numbers of
mature (i.e ., L3T4' or Lyt-2+) T cells derived from any source other than that
with which the experimental mice were reconstituted. Upon adoptive transfer,
it was found that nude mice reconstituted with negatively selected populations
of Lyt-2+ T cells rapidly rejected MHC class I-disparate skin allografts, whereas
nude mice reconstituted with negatively selected populations of L3T4'' T cells
rapidly rejected MHC class II- and minor H-disparate skin allografts. The
simplest interpretation of these observations was that the rejection specificities
expressed by adoptively transferred T cell populations merely reflected their
antigen specificities (43). However, such a perspective did not explain why
collaboration between phenotypically distinct populations of L3T4' and Lyt-2'
T cells was required for the rejection of H-Y-disparate skin allografts . Similarly,
even though multiple minor H-disparate skin allografts were rejected by isolated
L3T4+ T cell populations (Fig. 5, center), their rejection by T cell populations
containing both L3T4+ and Lyt-2+ cells was significantly more rapid (Fig. 5,
left), indicating that cell interactions between phenotypically distinct T cell
populations also enhanced the rejection of multiple minor H-disparate skin
allografts.
Consequently, we thought that a better understanding of the roles performed
by T cells in skin allograft rejection would result from the simultaneous consid-
eration of their Lyt phenotype, recognition specificity, and functional capabilities
(Table V). Because cytolytic T cell responses have been considered to be the in
vitro counterpart of in vivo graft rejection (44, 45), the T cell functions we
focused on were those involved in CTL responses, namely the stimulation of
lymphokine-mediated T cell help and the activation of lymphokine-responsive
Tk cells (15, 37). The usefulness of such an analysis is evident in Table V;
without exception, skin allograft rejection occurred only in mice reconstituted
with T cell populations that, as shown by in vitro assessment, contained both Th
and Tk cells specific for the alloantigens of the graft. Because T-inducer cells
for skin allograft rejection in vivo and Th cells for CTL responses in vitro are
identical in their Lyt phenotypes, antigen specificities, and ability to activate
effector cells, it is likely T-inducer and Th cells are one and the same. While we
have not shown that T-inducer cells mediate their helper function in vivo by1310 T CELL SUBSETS AND INTERACTIONS IN ALLOGRAFT REJECTION
TABLE V
Correlation ofIn Vitro T Cell Functions* with Observed In Vivo Rejection Responses
* References are cited in the text.
secreting lymphokines, we think it is highly likely that they do so, since given the
recognition specificities of T-inducer and T-effector cells, they are unable to
recognize each other directly. However, Dr. Kevin Lafferty (University of
Colorado, Barbara Davis Center, Denver, CO, personal communication) has
suggested thealternate possibility that activated macrophages, rather than soluble
lymphokines, perform the intermediary role in vivo between Th/T-inducer cells
and Tk/T-effector cells, such that Tk/T-effector cells are triggered only by
interacting with macrophages that had previously interacted with Th/T-inducer
cells. Since T-effector cells for skin allograft rejection in vivo and Tk cells for
CTL responses in vitroare identical in their Lyt phenotypes, antigen specificities,
and helper requirements, it is tempting to conclude that T-effector and Tk cells
are also one and the same. Indeed, it has been previously shown (46-49) that Tk
cells are among the cellular elements that infiltrate rejecting allografts. Never-
theless, it is not yet clear that the mechanism by which T-effector cells reject
skin allografts involves cell mediated cytolysis.
Consistent with the relationship between in vitro T cell responses and in vivo
allograft rejection, the present in vivo demonstration of a selective Th cell
deficiency in the failure of H-26 mice to reject Qal disparate skin allografts
parallels in vitro observations of a Th cell deficiency in Qal-specific CTL
responses (50, 51). Moreover, the ability of H-Y to function as a helper deter-
minant for the in vivo activation of anti-Qal T-effector cells to reject Qal-
disparate skin allografts (Table III) also parallels the reported ability of H-Y to
function as a helper determinant in vitro to activate anti-Qal Tk cells (50, 51).
While this study indicates that skin allograft rejection occurs only in those mice
Antigenic
disparity
relative to B10
Lyt phenotypes
of responding
H-26 T cells
In vitro T cell
Th
function
Tk
Skin graft
rejection
Fully allogeneic (DBA/2) Lyt-2+ + L3T4+ + + +
Lyt-2+ + + +
L3T4+ + + +
MHC class I (Inn 1) Lyt-2+ + L3T4+ + + +
Lyt-2+ + + +
L3T4+ + - -
MHC class II (bm12) Lyt-2++ L3T4+ + + +
Lyt-2+ - + -
L3T4+ + + +
H-Y Lyt-2+ + L3T4+ + + +
Lyt-2+ - + -
L3T4+ + - -
Multiple minors (BALB.B) Lyt-2+ + L3T4+ + + +
Lyt-2+ - + -
L3T4+ + + +
Qa-la (B6.Tlaa) Lyt-2+ + L3T4+ - + -
Kn'°s (bm6) Lyt-2+ + L3T4+ + + -ROSENBERG ET AL.
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containing both lymphokine-secreting Th and lymphokine-responsive Tk cells
reactive against the alloantigens of the graft, it should be emphasized that the
presence of both Th and Tk cells is not sufficient to predict that rejection will
occur. For example, the majority of B6 mice fail to reject bm6 skin allografts
despite the in vitro assessment that they contain both anti-Kbms Th and Tk cells
(Table V; reference 18), and despite their ability to generate anti-Kb,s CTL
responses in vitro (18). Indeed, the present demonstration that a selective Th
cell deficiency is responsible for the failure of H-26 mice to reject bm6 skin
allografts is consistent with our previous observations that H-26 mice contain
anti-Kb-6 L3T4+ Th cells but are deficient in anti-Kb,6 Lyt-2+ Th cells (18), and
that it is the Lyt-2+ Th cell population that initiates the rejection of MHC class
I-disparate skin allografts (9). Why do Kb,s-reactive L3T4+ Th cells function in
vitro to initiate anti-Kb,s CTL responses (18) yet apparently fail to function in
vivo to trigger rejection of Kbms skin allografts? Failing to function in vivo to
initiate skin allograft rejection is probably not unique to anti-Kb", L3T4+ Th
cells since we have never observed enhancement of any MHC class I rejection
response by L3T4+ Th cells (Fig. 5, compare left and right panels). We think at
least part of the explanation lies in the specificity of class I-allospecific L3T4+
Th cells for an antigenic complex composed of foreign class I plus self class 11
MHC determinants (19, 31, 37). We have recently shown that the Ia+ cells in
the skin are markedly deficient in their expression ofclass I MHC determinants
(52), so that the antigenic complex ofclass I plus class 11 MHC determinants may
not be formed in sufficient quantity in skin allografts to activate class I-allospe-
cific L3T4+ Th cells. Indeed, unlike class I-allospecific L3T4+ Th cells, class I-
allospecific Lyt-2+ Th cells recognize MHC class I allodeterminants directly so
that, in principle, Lyt-2+ Th cells can efficiently respond to allogeneic skin cells
by recognizing class I allodeterminants that are either present in large amounts
on the surface ofla- keratinocytes or are present in small amounts on the surface
ofIa+ Langerhans' cells. Since Ia- keratinocytes express on their surface 30 times
as much MHC class I as do Ia+ Langerhans' cells (52), it is somewhat surprising
that preliminary experiments indicate that class I-allospecific Lyt-2+ Th cells
respond to skin cells because they respond to the small amount of MHC class I
allodeterminants present on the surface of Ia+ Langerhans' cells (Mizuochi, T.,
S. Shimada, A. S. Rosenberg, S. W. Caughman, S. I. Katz, and A. Singer,
unpublished results). Thus, we think that despite the presence of both Th and
Tk cells, H-26 mice fail to reject bm6 skin allografts in vivo because the Kbms-
specific Th cells they contain are exclusively L3T4+ whose recognition require-
mentsarenotfulfilled bythe cellular elements constitutingthe bm6 skin allograft.
Much of the controversy surrounding the characterization of T cells involved
in allograft rejection have resulted from attempts to deduce function from
phenotype, even though T cell function does not strictly segregate with T cell
phenotype (16, 19). The present results strongly support previous conclusions
(1, 5, 7, 48) that both help and cytolytic T cell functions, whether provided by a
single dual function T cell or by interactions between two functionally distinct
T cells are necessary to initiate and mediate skin allograft rejection. However,
the present observation that Lyt-2+,L3T4- T cell populations are fully capable131 2 T CELL SUBSETS AND INTERACTIONS IN ALLOGRAFT REJECTION
ofrejecting skin allografts expressing MHC class I disparities appears to conflict
with the observation ofCobbold and Waldmann (53) that in vivo administration
ofanti-L3T4 antibody significantly inhibited the rejection offully allogeneic skin
allografts. Studies investigating this apparent discrepancy are in progress.
In conclusion, the present study indicates that skin allograft rejection can be
reasonably viewed as the in vivo endpoint ofan antigen-specific immune process
initiated by lymphokine-secreting Th cells and mediated by lymphokine respon-
sive Tk cells. Thus, a rejection response depends upon: (a) the presence of Th
and Tk cells each specific for alloantigens expressed by the graft, and (b) the
ability ofcellular elements within the skin allograft to fulfill the recognition and
activation requirements ofthe allospecific T cell populations present in the host.
Summary
In the present study we used an adoptive transfer model with athymic nude
mice to characterize the T cells involved in initiating and mediating skin allograft
rejection. It was found that skin allograft rejection in nude mice required the
transfer ofimmunocompetent T cells and that such reconstitution did not itself
stimulate the appearance of T cells derived from the nude host. Reconstitution
with isolated populations ofLyt-2'/L3T4- Tcells resulted in the rapid rejection
of MHC class I-disparate skin allografts, whereas reconstitution with isolated
populations of L3T4'/Lyt-2- T cells resulted in the rapid rejection of MHC
class I1-disparate and minor H-disparate skin allografts. By correlating these
rejection responses with the functional capabilities of antigen-specific T cells
contained within the reconstituting Lyt-2' and L3T4+ T cell populations, it was
noted that skin allografts were only rejected by mice that, as shown by in vitro
assessment, contained both lymphokine-secreting Th cells and lymphokine-re-
sponsive Tk cells specific for the alloantigens of the graft. The ability of two
such functionally distinct T cell subsets to interact in vivo to reject skin allografts
was directly demonstrated in H-Y-specific rejection responses by taking advan-
tage ofthe fact that H-Y-specific Th cells are L3T4+ while H-Y specific Tk cells
are Lyt-2'. Finally, the importance of in vivo interactions between functionally
distinct Th/T-inducer cells and T killer (Tk)/T-effector cells in skin allograft
rejection was demonstrated by the observation that normal B6 mice retain Qal'
and Kb"'6 skin allografts because of a selective deficiency in antigen-specific Th
cells, even though they contain T-effector cells that, when activated, are able to
reject such allografts.
Thus, the ability to reject skin allografts is neither unique to a specialized
subset of T cells with a given Lyt phenotype, nor unique to a specialized subset
of helper-independent effector T cells with so-called dual function capability.
Rather, skinallograft rejection can be mediatedbyin vivo collaborations between
T-inducer cells and T-effector cells, and the two interacting T cell subsets can
express different Lyt phenotypes as well as different antigen specificities.
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